See what Edwards, Alpheus Medical, and Explorer Surgical were up to this time last year.

Katie Hobbins, Managing Editor

December 22, 2022

1 Min Read
calendar (1).jpg
Image courtesy of Brian Jackson / Alamy Stock Photo

FDA Nod Allows Edwards to Treat Pulmonary Regurgitation Patients

The Irvine, CA-based company has FDA approval for the use of the Edwards Sapien 3 with the Alterra adaptive prestent for severe pulmonary regurgitation.

Ultrasound Drug-Device Offers Diffuse Treatment for Glioblastoma Multiforme

The device from Alpheus Medical employs an FDA-approved drug to visually distinguish tumor cells and then target those cells using sonodynamic therapy.

Medtronic Leverages Real-Time Remote Procedure Support

Explorer Surgical’s digital training platform has helped Medtronic during the pandemic and beyond.

Osseosurface Electronics Capture Real-Time Bone Data

Made of calcium phosphate ceramics, the sensors grow into the bone and can provide ongoing bone health data.

Accelerating Trends Toward Patient-Administered Biologic Therapies

How can drug delivery advance beyond the traditional vial and syringe?

What Medical Products Top Amazon’s Lists?

Check out these home-use medical products that top gift, wish, and best-seller lists this season.

Can Vagus Nerve Stimulation Treat Stroke?

New stroke therapy device expands discussion of what is ‘meaningful’ recovery.

About the Author(s)

Katie Hobbins

Managing Editor, MD+DI

Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like